BioPhenoMA
BioPhenoMA provides high-sensitivity detection and quantification of ultra-trace proteins to support pharmaceutical and reagent research. It uses an AI-powered platform combined with advanced proteomic assays to identify and measure proteins at very low concentrations, improving detection limits beyond standard methods. The company operates as a B2B analytical service for drug discovery, quasi-drug development, and reagent manufacturers, delivering quantitative results and data reports. BioPhenoMA primarily serves research and development teams in life sciences and biotech that require accurate protein measurement in early-stage discovery and validation.
BioPhenoMA
BioPhenoMA provides high-sensitivity detection and quantification of ultra-trace proteins to support pharmaceutical and reagent research. It uses an AI-powered platform combined with advanced proteomic assays to identify and measure proteins at very low concentrations, improving detection limits beyond standard methods. The company operates as a B2B analytical service for drug discovery, quasi-drug development, and reagent manufacturers, delivering quantitative results and data reports. BioPhenoMA primarily serves research and development teams in life sciences and biotech that require accurate protein measurement in early-stage discovery and validation.